Genomic Epidemiology of Extrapulmonary Nontuberculous Mycobacteria Isolates at Emerging Infections Program Sites-United States, 2019-2020

J Infect Dis. 2025 Apr 15;231(4):902-912. doi: 10.1093/infdis/jiae488.

Abstract

Background: Nontuberculous mycobacteria (NTM) cause pulmonary and extrapulmonary infections. Although isolation of NTM from clinical specimens has increased nationally, few studies delineated the molecular characteristics of extrapulmonary NTM.

Methods: Extrapulmonary isolates were collected by 4 Emerging Infections Program sites from October 2019 to March 2020 and underwent laboratory characterization, including matrix-assisted laser desorption ionization-time of flight mass spectrometry, Sanger DNA sequencing, and whole genome sequencing. Bioinformatics analyses were employed to identify species, sequence types (STs), antimicrobial resistance (AR), and virulence genes; isolates were further characterized by phylogenetic analyses.

Results: Among 45 isolates, the predominant species were Mycobacterium avium (n = 20, 44%), Mycobacterium chelonae (n = 7, 16%), and Mycobacterium fortuitum (n = 6, 13%). The collection represented 31 STs across 10 species; the most common ST was ST11 (M. avium, n = 7). M. fortuitum and Mycobacterium abscessus isolates harbored multiple genes conferring resistance to aminoglycosides, β-lactams, and macrolides. No known AR mutations were detected in rpoB, 16S, or 23S rRNAs. Slow-growing NTM species harbored multiple virulence genes, including type VII secretion components, adhesion factors, and phospholipase C.

Conclusions: Continued active laboratory- and population-based surveillance will further inform the prevalence of NTM species and STs, monitor emerging clones, and allow AR characterization.

Keywords: antimicrobial resistance; extrapulmonary NTM; molecular epidemiology; public health bioinformatics; whole genome sequencing.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Communicable Diseases, Emerging* / epidemiology
  • Communicable Diseases, Emerging* / microbiology
  • Drug Resistance, Bacterial / genetics
  • Female
  • Genome, Bacterial
  • Genomics
  • Humans
  • Male
  • Molecular Epidemiology
  • Mycobacterium Infections, Nontuberculous* / epidemiology
  • Mycobacterium Infections, Nontuberculous* / microbiology
  • Nontuberculous Mycobacteria* / classification
  • Nontuberculous Mycobacteria* / drug effects
  • Nontuberculous Mycobacteria* / genetics
  • Nontuberculous Mycobacteria* / isolation & purification
  • Phylogeny
  • United States / epidemiology
  • Virulence Factors / genetics
  • Whole Genome Sequencing

Substances

  • Anti-Bacterial Agents
  • Virulence Factors